Synchronised approach for intrauterine insemination in subfertile couples

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Cantineau, Astrid E P ^a   Janssen, Mirjam J ^b   Cohlen, Ben J ^c   Allersma, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ST JANSDAL HOSPITAL   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; GONADORELIN;

ADULT; BASAL BODY TEMPERATURE; FALLOPIAN TUBE; HUMAN; HYSTEROSALPINGOGRAPHY; INSEMINATION; INTRAUTERINE INSEMINATION; LAPAROSCOPY; LIVE BIRTH; MULTIPLE PREGNANCY; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEMINAL PLASMA; SENSITIVITY ANALYSIS; SPERMATOZOON; SPONTANEOUS ABORTION; SUBFERTILITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UTERINE TUBE PREGNANCY; AGONISTS; ARTIFICIAL INSEMINATION; BLOOD; BODY TEMPERATURE; FEMALE; INFERTILITY; MALE; META ANALYSIS; OVULATION DETECTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME; URINE; YOUNG ADULT;

ADULT; BODY TEMPERATURE; CHORIONIC GONADOTROPIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; INSEMINATION, ARTIFICIAL; LUTEINIZING HORMONE; MALE; OVULATION DETECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; YOUNG ADULT;

EID: 84925226833     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006942.pub3     Document Type: Review

References (92)

1. AboulGheit S. Pregnancy rates following three different timings of intrauterine insemination for women with unexplained infertility: A randomised controlled trial. Middle East Fertility Society Journal 2010;15:265-8.
2. Andrés Orós P, Lamarca Ballestero M, García Aguirre S, Ballesteros Moffa ME, Conte Martín P, Navarro Martín R, Duque Gallo JA. Triggering ovulation in intrauterine insemination cycles with gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropphin (hCG) [Inducción de la ovulación en ciclos de inseminación intrauterina con análogos de la GnRH (a-GnRH) versus hormona coriogonadotrópica humana (hCG)]. Revista Iberoamericana de Fertilidad 2008;25(4):223-8.
3. Claman P, Wilkie V, Collins D. Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy. Fertility and Sterility 2004;82(1):13-6.
4. da Silva ALB, Arbo E, Fanchin R. Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles: a randomized clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 2012;164:156-60.
5. Kyrou D, Kolibianakis EM, Fatemi HM, Grimbizis GF, Theodoridis TD, Camus M, et al. Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. Reproductive BioMedicine Online 2012;25(3):278-83.
6. Kyrou D, Riva A, Verpoest W, Fatemi HM, Tournaye H, Devroey P. What is the optimal moment for IUI in natural cycles? Human chorionic gonadotropin or luteinizing monitoring? Preliminary results of a randomized study. Fertility and Sterility 2010;94 Suppl 1:170 Abstract no. P-265.
7. Lewis V, Queenan J, Hoeger K, Stevens J, Guzick GS. Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial. Fertility and Sterility 2006;85(2):401-6.
8. Lorusso F, Palmisano M, Serrati G, Bassi E, Lamanna G, Vacca M, Depalo R. Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial. Gynecological Endocrinology 2008;24(11):644-8.
9. Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J. Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation of normal ovulatory cycles: a controlled study. Fertility and Sterility 1991;55(2):258-65.
10. Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J. A controlled study of human chorionic gonadotrophin induced ovulation versus urinary luteinizing hormone surge for timing of intrauterine insemination. Human Reproduction 1991;6(9):1247-51.
11. Nikbakht R, Hemadi M. Comparison of two doses of recombinant Human Chorionic Gonadotropin (rhCG) during ovulation induction in intrauterine insemination cycles: a prospective randomized clinical trial. International Journal of Pharmacology 2012;8(4):259-64.
12. Rahman SM, Karmakar D, Malhotra N, Kumar S. Timing of intrauterine insemination: an attempt to unravel the enigma. Archives of Gynecology and Obstetrics 2011;284:1023-7.
13. Sakhel K, Khedr M, Schwark S, Ashraf M, Fakih MH, Abuzeid M. Comparison of urinary and recombinant hCG during ovulation induction in IUI cycles: a prospective randomized clinical trial. Fertility and Sterility 2007;87(6):1357-62.
14. Schmidt-Sarosi C, Kaplan DR, Sarosi P, Essig MN, Licciardi FL, Keltz M, Levitz M. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist. Journal of Assisted Reproduction and Genetics 1995;12(3):167-74.
15. Scott RT, Bailey SA, Kost ER, Neal GS, Hofmann GE, Illions EH. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles. Fertility and Sterility 1994;61(5):872-9.
16. Shalev E, Geslevich Y, Matilsky M, Ben-Ami M. Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles. Human Reproduction 1995;10(9):2244-7.
17. Sharma S, Goswami S, Goswami SK, Ghosh S, Chattopadhyay R, Sarkar A, Chakravarty BN. Efficacy of GnRH agonist vs hCG as ovulation trigger in IUI cycle: a prospective randomised study. Human Reproduction 2011;26 Suppl 1:i 306. Abstract P-476.
18. Weiss A, Geslevich Y, Beck R, Lavie M, Ayeli V, Shalev E. Optimal timing of intra-uterine insemination for controlled ovarian stimulation utilizing gonadotropins with GnRH antagonists. Human Reproduction 2010;25(6 Suppl 1):i45-6. Abstract O-116.
19. Zreik TG, García Velasco JA, Habboosh MS, Olive DL, Arici A. Prospective, randomized crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine insemination in clomiphene citrate-stimulated treatment cycles. Fertility and Sterility 1999;71(6):1070-4.
20. Agarwal SK, Buyalos RP. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: Comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Human Reproduction 1995;10(2):328-31.
21. Arici A, Byrd W, Bradsha K, Kutteh WH, Marshburn P, Carr BR. Evaluation of clomiphene citrate and human chorionic gonadotropin treatment: a prospective, randomized, crossover study during intrauterine insemination cycles. Fertility and Sterility 1994;61(2):314-8.
22. Baroni E, Ragni G, Guermandi E, Riccaboni A, Arnoldi M, Scarduelli C, Crosignani PG. Timing of intrauterine insemination: the use of GnRH antagonist versus ovulation detection kit in FSH-stimulated cycles. Human Reproduction 2001;16 Suppl 1:138.
23. Barratt CL, Cooke S, Chauhan M, Cooke ID. A prospective randomized controlled trial comparing urinary luteinizing hormone dipsticks and basal body temperature charts with time donor insemination. Fertility and Sterility 1989;52(3):394-7.
24. Casadei L, Zamaro V, Calcagni M, Ticconi C, Dorrucci M, Piccione E. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: A comparison among three different regimes. European Journal of Obstetrics & Gynecology and Reproductive Biology 2006;129:155-61.
25. Cedrin-Durnerin I, Attalah M, Martin B, Fillion C, Tanguy M, Bellais E, et al. Timing of intra-uterine insemination after induction of ovulation with hCG: randomised study [Programmation de la date de l'insemination intra-uterine apres declenchement de l'ovulation par hCG. Etude randomisee]. Contraception Fertilite Sexualite 1993;21(5):431.
26. Check JH, Peymer M, Zaccardo M. Evaluation of whether using hCG to stimulate oocyte release helps or decreases pregnancy rates following intrauterine insemination. Gynecologic and Obstetric Investigation 1994;38(1):57-9.
27. Claman P, Wilkie V, Collins D. A short (335 h) compared with a long (395 h) interval between hCG injection and intrauterine insemination after superovulation therapy. Human Reproduction 2000;15:6-7.
28. Claman P, Wilkie V, Collins D. Timing intrauterine insemination either 33 or 39 hours after hCG yields the same pregnancy rates after super-ovulation therapy. A prospective randomized trial. The 20th Annual Meeting of the European Society of Human Reproduction and Embryology. 2004:i113-4.
29. Claraz E, Frobert C, Bremond A, Cottinet D. Significance of HCG injection for ovulation induction and of ovulation prediction factors in the practice of artificial insemination using donor sperm. A randomized study. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1989;18(8):1049-54.
30. Costa Franco AC, Pongiluppi Herbst M. Analyses from variables involved in the intrauterine insemination process in a human reproduction clinic. Jornal Brasileiro de Reproducao Assistida 2006;10(1):22-4.
31. Diaz I, Guillen A, Pacheco A, Requena A, García-Velasco JA. Comparison of hormonal profile at final oocyte maturation with GnRH agonist vs hCG in IVI cycles: preliminary study. Revista Iberoamericana de Fertilidad y Reproduccion Humana 2003;20(3):157-61.
32. Diaz I, Guillen A, Pacheco A, Requena A, Simon C, García Velasco J. Final oocyte maturation with GnRH agonist versus hCG in intrauterine insemination. Human Reproduction 2003;18 Suppl 1:134-5.
33. Diaz I, Guillen A, Pacheco A, Requena A, Garcia-Velasco JA. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination. The Journal of Reproductive Medicine 2008;53(1):33-9.
34. Egbase P, Grudzinskas J, Al Sharhan M, Ashkenani L. HCG or GnRH agonist to trigger ovulation in GnRH antagonist-treated intrauterine insemination cycles: a prospective randomized study. Human Reproduction 2002;17(Abstract book 1):2.
35. Federman CA, Demesic DA, Boone WR, Shapiro SS. Relative efficiency of therapeutic donor insemination using a luteinizing hormone monitor. Fertility and Sterility 1990;54(3):489-92.
36. Fischer R, Nakajima S, Gibson M, Brumsted J. Ovulation after intravenous and intramuscular human chorionic gonadotropin. Fertility and Sterility 1993;60:418-22.
37. Fondop JJ, Ventura B, Romoscanu I, Ibecheole V, Stalberg A, De Ziegler D. MiniHCG in mild COH responders for limiting multiple pregnancies. The 21st Annual Meeting of the European Society of Human Reproduction and Embryology. 2005:i113.
38. George K, George S, Chandy A, Raju R, Bala S. hCG administration offers no outcome benefit over spontaneous ovulation in anovulatory women treated with clomiphene citrate. Fertility and Sterility 2007;87(4):985-7.
39. Gerris J, De Vits A, Joostens M, Van Royen E. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin releasing hormone (100 and 500 ug), GnRH agonist (buserelin 500 ug) and human chorionic gonadotrophin (10000 IU). Human Reproduction 1995;10(1):56-62.
40. Gerrits MGF, van den Heuvel MW, Addo S, Mannaerts B, Peeters PAM. Safety, pharmacokinetics and ovulation induction of the first orally administered low molecular weight LH agonist. Basic & Clinical Pharmacology & Toxicology 2011;109 Suppl 1:70.
41. Ghanem ME, Bakre NI, Emam MA, Al Boghdady LA, Helal AS, Elmetwally AG, Hassan M, et al. The effect of timing of intrauterine insemination in relation to ovulation and the number of inseminations on cycle pregnancy rate in common infertility etiologies. Human Reproduction 2011;26(3):576-83.
42. Ghazizadeh S, Pourmatroud E, Shariat M, Masomi M, Bagheri M. Study of positive and negative consequences of using GnRH antagonist in intrauterine insemination cycles. International Journal of Fertility and Sterility 2009;3(2):56-61.
43. Ghosh Dastidar S, Ghosh Dastidar B. The impact of LH supplementation in controlled ovarian stimulation with recombinant FSH and GnRH antagonist in IUI cycle. Human Reproduction 2009;24 Suppl 1:i43. O-106.
44. International Recombinant Human Chorionic Gonadotropin Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertility and Sterility 2001;75(6):1111-8.
45. Khattab AF, Mustafa FA, Taylor PJ. The use of urine LH detection kits to time intrauterine insemination with donor sperm. Human Reproduction 2005;20(9):2542-5.
46. Kossoy LR, Hill GA, Parker RA, Rogers BJ, Dalglish CS, Herbert GM 3rd, Wentz AC. Luteinizing hormone and ovulation timing in a therapeutic donor insemination program using frozen semen. American Journal of Obstetrics and Gynecology 1989;160(5 part 1):1169-72.
47. Kotecki JA, Dzik A, Freitas GC, Soares JB, Bahamondes LG, Cavagna M. Comparison of Five different ovarian stimulation protocols for intrauterine insemination. A prospective randomized trial. 61st Annual Meeting of the American Society for Reproductive Medicine 2005;84 Suppl 1:93-4.
48. Lewis V, Guzick D. Clomiphene and intrauterine insemination (IUI) - what is the best way to time insemination?. Fertility and Sterility 2002;78 Suppl 1(3):154.
49. Lewis V, Guzick D. Is administration of hCG in a clomiphene cycle cost effective?. 59th Annual Meeting of the American Society for Reproductive Medicine 2003;80 Suppl 3:213.
50. Martinez AR, Bernardus RE, Vermeiden JPW, Schoemaker J. Time schedules of intrauterine insemination after urinary luteinizing hormone surge detection and pregnancy results. Gynecological Endocrinology 1994;8(1):1-5.
51. Meherji PK. Intrauterine insemination in the management of infertility. Indian Journal of Medical Research 2004;120(6):507-9.
52. Nulsen JC, Walsh S, Dumez S, Metzger DA. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstetrics and Gynecology 1993;82(5):780-6.
53. Odem RR, Durso NM, Long CA, Pineda JA, Strickler RC, Gast MJ. Therapeutic donor insemination: a prospective randomized study of scheduling methods. Fertility and Sterility 1991;55(5):976-82.
54. Panchal S, Nagori CB. Pre-hCG 3D and 3D power Doppler assessment of the follicle for improving pregnancy rates in intrauterine insemination cycles. Journal of Human Reproductive Sciences 2009;2(2):62-7.
55. Papageorgiou GA, Papageorgiou A, Zafrakas MA. Intrauterine insemination and mild ovarian hyperstimulation as a treatment for male subfertility. Human Reproduction 1995;Abstract book 2, 11th Annual Meeting of ESHRE, Hamburg:85.
56. Pierson R, Olatunbosun F, Baerwald A, de Moustier B, Saunders H, Loumaye E. Recombinant human luteinizing hormone for triggering follicular rupture: a dose finding study in ovulation induction. Fertility and Sterility 2002;78(3):56.
57. Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Human Reproduction 2005;20:1798-804.
58. Propst AM, Thoppil JJ, Groll JM, Frattarelli JL, Robinson RD, RetzloffMG. Pre-ovulatory vs ovulatory intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertility and Sterility 2007;88 Suppl 1:172-3.
59. Propst AM, Thoppil JJ, Groll JM, Frattarelli JL, Robinson RD, RetzloffMG. A single pre-ovulatory IUI at 12 hours after hCG trigger is comparable to a traditional IUI at 36 hours. Fertility and Sterility 2012;3 Suppl:S85-6.
60. Ragni G, Maggioni P, Guermandi E, Testa A, Baroni E, Colombo M, Crosignani PG. Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertility and Sterility 1999;72(4):619-22.
61. Ramon O, Matorras R, Corcostegui B, Meabe A, Burgos J, Exposito A, Crisol L. Ultrasound-guided artificial insemination: a randomized controlled trial. Human Reproduction 2009;24(5):1080-4.
62. Ramon O, Matorras R, Corcostegui B, Meabe A, Burgos J, Exposito A, Crisol L. Ultrasound guided artificial insemination: a randomized controlled trial. Human Reproduction 2009;24 Suppl 1:i45. O-114.
63. Robinson JN, Lockwood GM, Dalton JD, Franklin PA, Farr MM, Barlow DH. A randomized prospective study to assess the effect of the use of home urinary luteinizing hormone detection on the efficiency of donor insemination. Human Reproduction 1992;7(1):63-5.
64. Romeu A, Monzo A, Diez E, Peiro T, Fernandez P. Triggering ovulation for intrauterine insemination using a GnRH analog or HCG in highly purified FSH-stimulated cycles. Acta Obstetricia et Gynecologica Scandinavica 1997;76 Suppl:74.
65. Romeu A, Monzo A, Peiro T, Diez E, Peinado JA, Quintero. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles. Journal of Assisted Reproduction and Genetics 1997;14(9):518-24.
66. Sakhel K, Khedr M, Schwark S, Ashraf M, Fakih MH, Abuzeid M. Comparison between urinary and recombinant hCG during ovulation induction in IUI cycles: a prospective randomized clinical trial. 60th Annual Meeting of the American Society for Reproductive Medicine 2004;82 Suppl 2:238.
67. Scarpellini F, Lufino R, Benvenuto P, Scarpellini L, Sbracia M. Efficacy of biochemical vs biological monitoring during the "timing" of the chorionic gonadotropin administration in FSH and HMG stimulated cycles. Acta Europaea Fertilitatis 1991;22(6):329-32.
68. Shanis BS, Check JH. Efficacy of gonadotropin-releasing hormone agonists to induce ovulation following low-dose human menopausal gonadotropin stimulation. Recent Progress in Hormone Research 1995;50:483-6.
69. Silverberg KM, Johnson JV, Olive DL, Schenken RS. A prospective randomized trial to determine the optimal timing of intrauterine insemination following hCG administration after controlled ovarian hyperstimulation. Fertility and Sterility 1991;54:100.
70. Tavaniotou A, Devroey P. Effect of human chorionic gonadotropin on luteal luteinizing hormone concentration in natural cycles. Fertility and Sterility 2003;80(3):654-5.
71. Tonguc E, Var T, Onalan G, Altinbas S, Tokmak A, Karakas N, Gulerman C. Comparison of the effectiveness of single versus double intrauterine insemination with three different timing regimes. Fertility and Sterility 2010;94(4):1267-70.
72. Wang C, Horng S, Chang C, Huang H, Wang H, Soong Y. Delayed HCG injection and earlier insemination can improve the outcome of IUI - a novel and simplified protocol. 17th World Congress on Fertility and Sterility 2001;Abstract book:189.
73. Wang CW, Horng SG, Chen CK, Wang HS, Huang HY, Soong YK. Delayed timing of human chorionic gonadotropin injection in combination with earlier insemination can improve the outcome of intrauterine insemination. Human Reproduction 2006;21 Suppl:i119.
74. Aydin Y, Hassa H, Oge T, Tokgoz Y. A randomized study of simultaneous hCG administration with intrauterine insemination in stimulated cycles. European Journal of Obstetrics & Gynecology and Reproductive Biology 2013;170:444-8.
75. Blockeel C, Knez J, Polyzos NP, De Vos M, Camus M, Tournaye H. Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT. Human Reproduction 2014;29(4):697-703.
76. Blockeel C, Polyzos N, Ermini B, Riva A, Stoop D, Tournaye H, Devroey P. Timing of IUI 24 or 48 hours after spontaneous LH peak. ClinicalTrials.gov June 29, 2012.
77. Dehghani-Firouzabai R, Aflatoonian A, Davar R, Farid-Mojtahedi M. A comparison of pregnancy rate before and after the administration of HCG in intrauterine insemination. Archives of Gynecology and Obstetrics 2014;29(2):429-32.
78. Mostafa MS, El Huseiny AM, Soliman BS, Mohammed MM. Effect of postponing hCG injection after intrauterine insemination on pregnancy rate. Middle East Fertility Society Journal 2014;19(3):183-6.
79. Combining Urinary Luteinizing hormone Testing with ultrasound monitoring in intrauterine insemination cycles. Ongoing study January 2011.
80. Andersen AG, Als-Nielsen B, Hornnes PJ, Franch Andersen L. Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Human Reproduction 1995;10(12):3202-5.
81. Cantineau AE, Cohlen BJ, Dutch IUI Study Group. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study. Fertility and Sterility 2007; Vol. 88, issue 1:107-12.
82. Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Human Reproduction 1998;13(6):1553-8.
83. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Human Reproduction Update 2010;16(3):231-45.
84. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
85. Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertility and Sterility 2006;13:607-12.
86. Kruger TF, Du Toit TC, Franken DR, Acosta AA, Oehninger SC, Menkveld R, et al. A new computerized method of reading sperm morphology (strict criteria) is as efficient as technician reading. Fertility and Sterility 1993;59(1):202-9.
87. Miller PB, Soules MR. The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women. Obstetrics and Gynecology 1996;87:13-7.
88. Steures P, van der Steeg JW, Hompes PG, Habbema JD, Eijkemans MJ, Broekmans FJ, et al. Collaborative Effort on the Clinical Evaluation in Reproductive Medicine. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet 2006;15(368 (9531)):216-21.
89. World Health Organization. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. American Journal of Obstetrics and Gynecology 1980;138(4):383-90.
90. World Health Organization. Laboratory Manual for SemenAnalysis and Sperm Cervical Mucus Interaction, revised edition. London/New York: Cambridge University Press, 1987.
91. World Health Organization. WHO laboratory manual for the examination of human semen and sperm cervical mucus interaction. Cambridge: Cambridge University Press, 1992.
92. World Health Organisation. WHO manual for the examination and processing of human semen. Geneva: World Health Organisation, 2010.